July 27, 2022
Written by Jing Ping Yeo and Charles Warne Adaptive designs are studies that “include a prospectively planned..
Read article
June 28, 2022
Founded in 1987 by Cyrus Mehta and Nitin Patel, research scientists at Harvard University and MIT respectively and..
Read article
March 18, 2022
Real world evidence (RWE) provides a large and growing source of insights into drug uptake and safety. It is..
Read article
March 11, 2022
Every year, sponsors hesitating to use a complex innovative clinical trial design routinely miss opportunities to..
Read article
February 18, 2022
Data is the most crucial asset of any clinical trial and hence, sponsors cannot jeopardize collecting clean..
Read article
February 11, 2022
Adopting data standards such as CDISC in the early phase of clinical drug development contributes to the consolidation..
Read article
February 4, 2022
The ability to conduct data-driven and quantitatively rigorous feasibility studies, is often key to successful trial..
Read article
January 21, 2022
For our first Winter Weekend Read, Cytel presents How to Use and Interpret the Results of a Platform Trial, a JAMA..
Read article
December 23, 2021
Cytel blogs bring you debate and discussion of the newest trends in statistics and quantitative strategy. In 2021, our..
Read article
